Tag: JNJ
-
3 High-Yield Dividend ETFs to Protect Your Portfolio From Market Volatility
In times of market volatility, investors can strengthen their portfolios by incorporating diversified, income-producing dividend ETFs.
-
3 High-Yield Dividend Stocks to Buy and Hold Forever
High-yield dividend stocks can help investors generate passive income while adding stability during volatile markets.
-
Protect Your Portfolio with 3 High-Yielding Dividend ETFs
In uncertain markets, dividend ETFs —especially those emphasizing companies with long histories of growing payouts—can help anchor your portfolio.
-
3 of the Best High-Yielding ETFs to Own Right Now
High-yielding ETFs can be powerful tools for building a steady stream of passive income, particularly for retirees or those nearing retirement
-
3 High-Yield Dividend Stocks to Buy and Hold Forever
Investing in high-yielding dividend stocks helps generate passive income and act as defensive, stable investments during times of massive volatility.
-
5 Retirement Income ETFs That Can Deliver a Monthly Paycheck
For many investors, the goal of retirement isn’t just growth — it’s reliable income. That’s why retirement income ETFs and monthly income ETFs have become essential tools for building passive income in retirement without having to sell assets during market downturns. After spending years building up your nest egg, you want to step into the…
-
KMB Stock Falls After Earnings, but “Value” May be the Key
Kimberly-Clark Corp. (NYSE: KMB) stock is down after its earnings report on Jan. 27. The company was expected to give investors a snapshot of the consumer. It did just that, and the word for KMB stock, as well as many consumer staples stocks this earnings season, may once again be “value.” The company’s fourth-quarter 2025 report showed that its focus…
-
Johnson & Johnson Earnings Power Shifts Into Higher Gear
Johnson & Johnson’s latest earnings report shows a mature healthcare giant acting more like a growth stock again, and investors are taking notice. In Q4 2025, Johnson & Johnson (NYSE: JNJ) delivered 9.1% reported sales growth to 24.6 billion, with operational growth of 7.1% and adjusted operational growth of 6.1%. Numbers like that should be…
-
The Dogs of the Dow for New Year 2026
Every year, one of the best strategies is the Dogs of the Dow. You simply buy a basket of underperformers on the Dow Jones Industrial Average (DJIA) that pay dividends, and sell them by the end of the year. The Strategy Behind the Dogs of the Dow The Dogs of the Dow strategy is made…
-
The Dogs of the Dow: A Year-End Dividend Opportunity
One of the best year-end investment strategies is the Dogs of the Dow. Granted, some analysts say it’s an antiquated strategy with low success rates. But history proves they still have plenty of bite. In fact, having traded the Dogs of the Dow since 2016, I can tell you it’s still a solid strategy with dividend…